EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC 4.0

The ‘Prostate Embolisation AS first‐line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P‐ EASY ADVANCE) : a randomised controlled trial of prostate embolisation vs medication for BPH

Nicholas Brown iD, Anthony Kiosoglous, Stephanie Castree, Sepinoud Firouzmand, Rhiannon McBean, Duncan G Walker, Sean Wallace, Boon Kua, Troy Gianduzzo, Rachel C Esler, Peter Campbell, Joseph Schoeman und 1 weitere

BJU International · 2024-12 · 134 (S2) · 38-46

DOI: 10.1111/bju.16479 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift BJU International, online erschienen am 13.08.2024. Verfasst von Nicholas Brown und 12 weiteren Autor:innen. Beteiligte Einrichtung: The University of Queensland, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Embolization, Therapeutic, Prostate, Tamsulosin. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare prostate artery embolisation (PAE) to the combination of tamsulosin and dutasteride therapy as a potential first‐line therapy for obstructive benign prostatic hyperplasia (BPH) in treatment‐naïve patients in the ‘Prostate Embolisation AS first‐line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P‐EASY ADVANCE). Patients and Methods A total of 39 men with enlarged prostates, moderate–severe lower urinary tract symptoms (LUTS) and obstructed/equivocal urodynamic studies (UDS), and who had no prior treatment for BPH, were randomised to receive either combined medical therapy with tamsulosin and dutasteride (medication) or PAE. Follow‐up UDS, International Prostate Symptom Score (IPSS), uroflowmetry and ultrasound were performed at short‐ to medium‐term intervals following interventions and compared to baseline.

Results

The medication and PAE treatment groups had similar baseline characteristics, including prostate volumes (87.8 and 85.4 mL respectively), maximum urinary flow rate (Q max ; 6.5 and 6.6 mL/s, respectively), IPSS (19.5 and 21, respectively) and obstructed UDS (79% and 74%, respectively). Both interventions improved voiding and bladder outflow obstruction from baseline, with more patients unobstructed after PAE (63%) compared to medication (28%) ( P = 0.03). PAE patients had significantly greater reductions in prostate size ( P < 0.001), incomplete emptying ( P = 0.002), total IPSS ( P = 0.032), Q max ( P = 0.006) and quality of life ( P = 0.001). Altered ejaculation, erectile dysfunction and nausea were more common in the medication group.

Conclusion

Prostate artery embolisation was more effective than combined medical therapy at reducing urinary obstruction, decreasing prostate volume and improving LUTS in patients with BPH who had not previously been treated. This is the first randomised control study to compare PAE and combined medical therapy in exclusively treatment‐naïve patients and raises the potential of PAE as an alternative early treatment option for BPH. Further randomised comparative trials are planned to further validate the role of PAE in mitigating obstructive BPH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaEmbolization, TherapeuticProstateTamsulosinDutasterideHumansMaleAgedMiddle AgedTreatment Outcome5-alpha Reductase InhibitorsLower Urinary Tract SymptomsAdrenergic alpha-1 Receptor AntagonistsDrug Therapy, Combination

Stichwörter der Autor:innen

benign prostatic hyperplasiaembolisationmedical therapyurinary tract symptomsurodynamics

Substanzen

TamsulosinDutasteride5-alpha Reductase InhibitorsAdrenergic alpha-1 Receptor Antagonists

Autor:innen und Institutionen

  • The University of Queensland, Brisbane, Queensland, Australia.
  • I-MED Radiology, Brisbane, Queensland, Australia.
  • Urology Craft Group, The Wesley Hospital, Auchenflower, Queensland, Australia.

ORCID-Profile: Nicholas Brown, John Yaxley

Zitieren

APA

Brown, N., Kiosoglous, A., Castree, S., Firouzmand, S., McBean, R., Walker, D. G., Wallace, S., Kua, B., Gianduzzo, T., Esler, R. C., Campbell, P., Schoeman, J., & Yaxley, J. (2024). The ‘Prostate Embolisation AS first‐line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P‐ EASY ADVANCE) : a randomised controlled trial of prostate embolisation vs medication for BPH. BJU International, 134(S2), 38-46. https://doi.org/10.1111/bju.16479

Vancouver

Brown N, Kiosoglous A, Castree S, Firouzmand S, McBean R, Walker DG, et al. The ‘Prostate Embolisation AS first‐line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P‐ EASY ADVANCE) : a randomised controlled trial of prostate embolisation vs medication for BPH. BJU International. 2024;134(S2):38-46. doi:10.1111/bju.16479

BibTeX
@article{Brown2024,
  author = {Brown, Nicholas and Kiosoglous, Anthony and Castree, Stephanie and Firouzmand, Sepinoud and McBean, Rhiannon and Walker, Duncan G and Wallace, Sean and Kua, Boon and Gianduzzo, Troy and Esler, Rachel C and Campbell, Peter and Schoeman, Joseph and Yaxley, John},
  title = {The ‘Prostate Embolisation AS first‐line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P‐ EASY ADVANCE) : a randomised controlled trial of prostate embolisation vs medication for BPH},
  journal = {BJU International},
  year = {2024},
  volume = {134},
  number = {S2},
  pages = {38--46},
  doi = {10.1111/bju.16479}
}
Kostenlos starten →